相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of inflammation and oxidative stress in atrial fibrillation
Jie Li et al.
HEART RHYTHM (2010)
Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes
Lin Lu et al.
ATHEROSCLEROSIS (2009)
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
Xiao Xiang Yan et al.
ATHEROSCLEROSIS (2009)
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Francesca Santilli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis Observations from the Dallas Heart Study
Jason B. Lindsey et al.
DIABETES CARE (2009)
The dialogue between diabetes and diastole
Loek van Heerebeek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice
Jan M. Nielsen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
Ravichandran Ramasamy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Advanced glycation endproducts in chronic heart failure
Andries J. Smit et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
Naoto Katakami et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Soluble receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure
Yo Koyama et al.
JOURNAL OF CARDIAC FAILURE (2008)
Clinical and prognostic value of advanced glycation end-products in chronic heart failure
Jasper W. L. Hartog et al.
EUROPEAN HEART JOURNAL (2007)
Advanced glycation end-products (AGES) and heart failure: Pathophysiology and clinical implications
Jasper W. L. Hartog et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease
Kazuo Nakamura et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Diego Geroldi et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Receptor for advanced-glycation end products - Key modulator of myocardial ischemic injury
LG Bucciarelli et al.
CIRCULATION (2006)
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
T Wendt et al.
ATHEROSCLEROSIS (2006)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis
JM Forbes et al.
DIABETES (2004)
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques - Role of glycemic control
F Cipollone et al.
CIRCULATION (2003)
Negative consequences of glycation
M Brownlee
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
分享论文
